[Ecteinascidin 743].
Lansiaux
A
A
Laboratoire de pharmacologie antitumorale, Centre Oscar-Lambret, Inserm U.524, Lille.
Bailly
C
C
D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000494:pharmacology* / Q000627:therapeutic use; D017321:Clinical Trials, Phase I as Topic; D004273:DNA, Neoplasm / Q000187:drug effects*; D004149:Dioxoles / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007546:Isoquinolines / Q000494:pharmacology* / Q000627:therapeutic use; D044005:Tetrahydroisoquinolines; D000077606:Trabectedin; D014407:Tumor Cells, Cultured / Q000187:drug effects
D018906:Antineoplastic Agents, Alkylating; D004273:DNA, Neoplasm; D004149:Dioxoles; D007546:Isoquinolines; D044005:Tetrahydroisoquinolines; D000077606:Trabectedin